Dramatic Response of Brain Metastasis from <i>EGFR</i>-mutation-positive NSCLC to Dacomitinib

Volume: 59, Issue: 14, Pages: 1739 - 1740
Published: Jul 15, 2020
Abstract
The central nervous system efficacy of dacomitinib, a key agent used in the treatment of epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC), is unclear. We herein present our experience in the use of dacomitinib for the treatment of multiple brain metastatic lesions from EGFR-mutation-positive NSCLC in an elderly patient. This case report demonstrates that dacomitinib can be an essential treatment option for...
Paper Details
Title
Dramatic Response of Brain Metastasis from <i>EGFR</i>-mutation-positive NSCLC to Dacomitinib
Published Date
Jul 15, 2020
Volume
59
Issue
14
Pages
1739 - 1740
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.